EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bonesupport Holding AB's Enterprise Value is €1,367.8 Mil.
Bonesupport Holding AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €22.4 Mil. Therefore, Bonesupport Holding AB's EV-to-FCF for today is 61.02.
The historical rank and industry rank for Bonesupport Holding AB's EV-to-FCF or its related term are showing as below:
STU:2B4'
s EV-to-FCF Range Over the Past 10 Years
Min: -76291.37 Med: -13.91 Max: 443.44
Current: 62.1
During the past 12 years, the highest EV-to-FCF of Bonesupport Holding AB was 443.44. The lowest was -76291.37. And the median was -13.91.
STU:2B4's EV-to-FCF is ranked worse than 81.73% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.355
vs STU:2B4: 62.10
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bonesupport Holding AB (STU:2B4) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bonesupport Holding AB's PE Ratio (TTM) for today is calculated as:
Bonesupport Holding AB's share price for today is €21.62.
Bonesupport Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.254.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonesupport Holding AB EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Bonesupport Holding AB's EV-to-FCF falls into.
Bonesupport Holding AB's current Enterprise Value is €1,367.8 Mil.
Bonesupport Holding AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €22.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonesupport Holding AB (STU:2B4) has a EV-to-FCF of 61.02 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bonesupport Holding AB and its competitors. According to the industry distribution chart, Bonesupport Holding AB ranks #340 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 81.7%.
Is Bonesupport Holding AB's EV-to-FCF too high?
Bonesupport Holding AB's current EV-to-FCF is 61.02. The Medical Devices & Instruments industry median EV-to-FCF is 23.36. Bonesupport Holding AB's value of 61.02 is 161.3% above this industry median. Based on the distribution chart, Bonesupport Holding AB ranks #340 out of 416 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bonesupport Holding AB has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonesupport Holding AB ranks #340 out of 416 companies for EV-to-FCF. This places Bonesupport Holding AB in the lower half of its industry. The industry median EV-to-FCF is 23.36. Bonesupport Holding AB's value of 61.02 is 161.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.36, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonesupport Holding AB's current EV-to-FCF of 61.02 is 161.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bonesupport Holding AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonesupport Holding AB's current EV-to-FCF is 61.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (STU:2B4) is currently considered Significantly Undervalued. The stock's GF Value™ is €39.58, compared to a current price of €21.62 — trading 45.4% below its estimated fair value. The current EV-to-FCF is 61.02 and 161.3% above the Medical Devices & Instruments industry median of 23.36. Bonesupport Holding AB's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Bonesupport Holding AB (STU:2B4), the current EV-to-FCF is 61.02 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonesupport Holding AB (STU:2B4) Overvalued in 2026?
Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued.
The current stock price of €21.62 is trading 45.4% below its estimated GF Value™ of €39.58.
GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.
Key valuation signals for STU:2B4:
EV-to-FCF: 61.02
GF Value™: €39.58 vs. price of €21.62 (45.4% below fair value)
Industry Position: 161.3% above the Medical Devices & Instruments median (#340 of 416)
No single metric tells the full story. See the STU:2B4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
81GF Score
Get the complete analysis for STU:2B4
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:2B4 has been successfully added to your 
